{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_thiazolidinediones",
          "name": "Thiazolidinediones"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "name": "Sodium-glucose cotransporter-2 inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_glitazones",
          "name": "Glitazones"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_progestins",
          "name": "Progestins"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.2,
          "safety_risk": 0.8,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Severe hypertriglyceridaemia",
              "pro": [
                "H1"
              ],
              "con": [
                "n_adv_hypertriglyceridaemia"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Gemfibrozil has a known mechanism related to the disease."
          ],
          "safety_risk": [
            "Potential risks associated with hypertriglyceridaemia might outweigh the therapeutic effects."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.2,
          "safety_risk": 0.8,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Severe hypertriglyceridaemia",
              "pro": [
                "H2"
              ],
              "con": [
                "n_adv_hypertriglyceridaemia"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Fenofibrate is indicated for treating the condition."
          ],
          "safety_risk": [
            "High risk of hypertriglyceridaemia may diminish the benefits of Fenofibrate."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.2,
          "safety_risk": 0.8,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Severe hypertriglyceridaemia",
              "pro": [
                "H3"
              ],
              "con": [
                "n_adv_hypertriglyceridaemia"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Clofibrate contributes effectively to the disease state."
          ],
          "safety_risk": [
            "The risk of hypertriglyceridaemia may counteract Clofibrate's benefits."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.2,
          "safety_risk": 0.8,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Severe hypertriglyceridaemia",
              "pro": [
                "H4"
              ],
              "con": [
                "n_adv_hypertriglyceridaemia"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Niacin is recognized to impact levels relevant to the condition."
          ],
          "safety_risk": [
            "High hypertriglyceridaemia risk may negate potential benefits of Niacin."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.2,
          "safety_risk": 0.8,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.3
        },
        "graph_signals": {
          "support_weight": 1.8,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "Severe hypertriglyceridaemia",
              "pro": [
                "H5"
              ],
              "con": [
                "n_adv_hypertriglyceridaemia"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Estrogens have a known association with the disease."
          ],
          "safety_risk": [
            "High risk of hypertriglyceridaemia may outweigh the benefits of Estrogens."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_estrogens",
          "type": "Drug",
          "label": "Estrogens",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_thiazolidinediones",
          "type": "Drug",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_sglt2_inhibitors",
          "type": "Drug",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_glitazones",
          "type": "Drug",
          "label": "Glitazones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_progestins",
          "type": "Drug",
          "label": "Progestins",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_gemfibrozil",
          "type": "Target",
          "label": "Off-target effects of Gemfibrozil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_fenofibrate",
          "type": "Target",
          "label": "Off-target effects of Fenofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_clofibrate",
          "type": "Target",
          "label": "Off-target effects of Clofibrate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_niacin",
          "type": "Target",
          "label": "Off-target effects of Niacin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_estrogens",
          "type": "Target",
          "label": "Off-target effects of Estrogens",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_thiazolidinediones",
          "type": "Target",
          "label": "Off-target effects of Thiazolidinediones",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_hypertriglyceridaemia",
          "type": "Pathway",
          "label": "Risk pathway for Severe hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_hypertriglyceridaemia",
          "type": "Phenotype",
          "label": "Adverse Phenotype from Drug-Induced Hypertriglyceridaemia",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Clofibrate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_clofibrate",
          "type": "Drug",
          "label": "Clofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Niacin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Estrogens",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_estrogens",
          "type": "Drug",
          "label": "Estrogens",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_thiazolidinediones",
          "type": "Drug",
          "label": "Thiazolidinediones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_sodium_glucose_cotransporter_2_inhibitors",
          "type": "Drug",
          "label": "Sodium-glucose cotransporter-2 inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Bosentan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Glitazones",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_glitazones",
          "type": "Drug",
          "label": "Glitazones",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Progestins",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_progestins",
          "type": "Drug",
          "label": "Progestins",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_gemfibrozil",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Gemfibrozil常用于降低甘油三酯"
        },
        {
          "source": "n_fenofibrate",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Fenofibrate被用来治疗高甘油三酯血症"
        },
        {
          "source": "n_clofibrate",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Clofibrate也用于治疗高甘油三酯血症"
        },
        {
          "source": "n_niacin",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Niacin在降低甘油三酯方面有效"
        },
        {
          "source": "n_estrogens",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Estrogens与甘油三酯水平的调节有关"
        },
        {
          "source": "n_thiazolidinediones",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Thiazolidinediones影响脂质代谢"
        },
        {
          "source": "n_sglt2_inhibitors",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "SGLT2抑制剂可能影响脂质水平"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Corticosteroids可增加血糖与甘油三酯"
        },
        {
          "source": "n_bosentan",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Bosentan可能影响脂质代谢"
        },
        {
          "source": "n_glitazones",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Glitazones与脂肪代谢相关"
        },
        {
          "source": "n_beta_blockers",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Beta-blockers可能导致甘油三酯升高"
        },
        {
          "source": "n_progestins",
          "target": "n_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Progestins影响脂质水平"
        },
        {
          "source": "n_gemfibrozil",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_fenofibrate",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_clofibrate",
          "target": "H3",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_niacin",
          "target": "H4",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_estrogens",
          "target": "H5",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_thiazolidinediones",
          "target": "H6",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_sglt2_inhibitors",
          "target": "H7",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_corticosteroids",
          "target": "H8",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_bosentan",
          "target": "H9",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_glitazones",
          "target": "H10",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_beta_blockers",
          "target": "H11",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "n_progestins",
          "target": "H12",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "直接关联至病理状态"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "n_ot_gemfibrozil",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知有影响脂质代谢的旁路"
        },
        {
          "source": "drug_fenofibrate",
          "target": "n_ot_fenofibrate",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致不良脂质水平升高"
        },
        {
          "source": "drug_clofibrate",
          "target": "n_ot_clofibrate",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "对脂肪代谢的干预可能加重风险"
        },
        {
          "source": "drug_niacin",
          "target": "n_ot_niacin",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "已知的副作用与脂质变化相关"
        },
        {
          "source": "drug_estrogens",
          "target": "n_ot_estrogens",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能对血脂产生影响"
        },
        {
          "source": "drug_thiazolidinediones",
          "target": "n_ot_thiazolidinediones",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与脂质代谢障碍有关"
        },
        {
          "source": "n_ot_gemfibrozil",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能引发脂类代谢异常"
        },
        {
          "source": "n_ot_fenofibrate",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与高甘油三酯风险相关"
        },
        {
          "source": "n_ot_clofibrate",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能加剧高甘油三酯问题"
        },
        {
          "source": "n_ot_niacin",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与脂质问题相互作用"
        },
        {
          "source": "n_ot_estrogens",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能影响甘油三酯水平"
        },
        {
          "source": "n_ot_thiazolidinediones",
          "target": "n_rp_hypertriglyceridaemia",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "与代谢综合征有关"
        },
        {
          "source": "n_rp_hypertriglyceridaemia",
          "target": "n_adv_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "导致甘油三酯水平显著升高"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Gemfibrozil 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Fenofibrate 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Clofibrate 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Niacin 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Estrogens 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Thiazolidinediones 的获益"
        },
        {
          "source": "n_adv_hypertriglyceridaemia",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "高甘油三酯风险抵消 Sodium-glucose cotransporter-2 inhibitors 的获益"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H1_round2",
        "key_assumptions": [
          "Gemfibrozil directly links to Severe hypertriglyceridaemia",
          "Safety risks concerning high triglycerides need further validation"
        ],
        "caveats": [
          "Safety profile in the context of existing contraindications remains unclear"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H2_round2",
        "key_assumptions": [
          "Fenofibrate directly supports treatment for Severe hypertriglyceridaemia",
          "Therapeutic effects may be overshadowed by safety risks"
        ],
        "caveats": [
          "Ongoing safety concerns regarding adverse effects on triglyceride levels"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_clofibrate",
          "name": "Clofibrate"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H3_round2",
        "key_assumptions": [
          "Clofibrate is effectively indicated for addressing Severe hypertriglyceridaemia",
          "Safety considerations may impede its therapeutic efficacy"
        ],
        "caveats": [
          "Concerning risk profile requires more extensive evaluation"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H4_round2",
        "key_assumptions": [
          "Niacin impacts triglyceride levels positively",
          "Existing safety risks need comprehensive review"
        ],
        "caveats": [
          "Potential hazards regarding triglyceride elevation must be addressed"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_estrogens",
          "name": "Estrogens"
        },
        "score": 0.42,
        "graph_snapshot_ref": "GE_H5_round2",
        "key_assumptions": [
          "Estrogens have roles in triglyceride regulation",
          "Safety concerns in hypertriglyceridaemia are significant"
        ],
        "caveats": [
          "The therapeutic advantage versus hypertriglyceridaemia risk remains unproven"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Severe hypertriglyceridaemia",
          "reason": "Each candidate links to Severe hypertriglyceridaemia with significant conflicts regarding safety."
        }
      ],
      "remaining_gaps": [
        "Risk profiles for drugs in the context of hypertriglyceridaemia need further clarification.",
        "Indications against use must be thoroughly explored with stronger connections."
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B"
          ],
          "impact_summary": "Initial candidates provided base connections to hypertriglyceridaemia."
        },
        {
          "round": 2,
          "seeds": [
            "C",
            "D"
          ],
          "impact_summary": "Identified ongoing safety conflicts that need addressing."
        }
      ],
      "lessons": [
        "Clarifying drug safety in relation to contraindications is crucial for evaluating efficacy.",
        "Future candidates should come equipped with robust safety profiles regarding lipid metabolism."
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "Reassess contraindications concerning triglyceride levels for existing drug candidates."
      },
      {
        "role": "Skeptic",
        "patch": "Focus on evidencing clear parameters of safety versus therapeutic benefit."
      },
      {
        "role": "Explorer",
        "patch": "Pursue creating a rich pool of candidates with distinct mechanisms and thorough safety assessments."
      }
    ],
    "heuristics": [
      {
        "when": "Hypertriglyceridaemia",
        "then": "Evaluate safety risks rigorously before proposing drug usage."
      },
      {
        "when": "Drug classification",
        "then": "Prioritize alternative options with better safety profiles."
      }
    ]
  }
}